The Significance of Excepient...a Review Array Section Review of Article

##plugins.themes.academic_pro.article.main##

Sujata Laxman Ramteke

Abstract

Significance of Excipients………A Review


 


Vd. Sujata Ramteke (PG scholar), Guide Vd. Avinash Chougule, HOD – Vd. Mahesh Inamdar, Department of Ras-shastra & Bhaishajya Kalpana, Shri Annasaheb Dange Ayurvedic Medical College, Ashta, (Dist) Sangli


 


 


Abstract


An excipient is a non-therapeutic substance and active ingredients which are essentially included in the development and designing of drug products. It is used for bulking up solid formulations and long-term stabilization. Excipient plays an important role in formulation that decide dosage form as well as Pharmacokinetics and pharmacodynamics of medicine. It also improves dissolution rate and bioavailability of the drug and also improve bulkiness, disintegration. Excipients can initiate, participate or propagate in chemical or physical interactions with drug compounds. Excipients as like other active pharmaceutical ingredients also need to be standardize and stabilize. Specific excipients are best suited for a particular dosage form so proper selection of the excipients is very much important as various interactions take place during its course of stay in formulation.


 


Keywords: Excipient, Formulation, bioavailability, pharmaceutical ingredients.

##plugins.themes.academic_pro.article.details##

How to Cite
Ramteke, S. L. (2018). The Significance of Excepient.a Review: Array. Ayurline: International Journal of Research in Indian Medicine, 2(5th). https://doi.org/10.52482/ayurline.v2i5th.136

References

    References: -
    1. Anonymous: WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    Fortieth report, Geneva: World Health Organization; 2006. WHO Technical Report Series No-
    937:183.

    2. Pifferi G and Restani P: The safety of pharmaceutical excipients. Il Farmaco 2003; 58:541-50.

    3. Pifferi G and Restani P: The safety of pharmaceutical excipients. IL Farmaco 2003; 58: 541-
    50.

    4 . Anonymous: Good manufacturing practices: supplementary guidelines for the manufacture
    of pharmaceutical excipients. WHO Expert Committee on Specifications for Pharmaceutical
    Preparations. Thirty-fifth report.Geneva: World Health Organization; 1999: Annex 5 (WHO
    Technical Report Series, No. 885).

    5 .Apte S P and Ugwu S O: A review and classification of Emerging excipients in parenteral
    medications. Pharmaceutical Technology 2003; 27:46.
    6. Sharma PV: Dravyaguna Vijanana Vol-1. Choukhambha Bharati academy Varanasi, 2006.
    7. Charak: Charak Samhita Sutrasthana 1/24.
    8. Charak: Charak Samhita Sutrasthana 9/3.
    9. Anthony Cerulli: Somatic Lessons: Narrating Patient-hood and Illness in Indian Medical
    Literature. SUNY Press 2011. p. 37.

    10. Patel S, Agrawal S and Singh L B: Natural Binding Agents in Tablet Formulation. Int J Pharm
    & Bio Archives 2012; 3:466-73.

    11. ThakurM, Porwal P, Pal P, Shukla K and Mahajan S C: Development of standardization of
    trikatu churna: A spectrophotometric approach. Int J of Pharm & Life Sci 2012; 3: 2254-58.

    12. Atal CK, Dubey RK and Singh J: Biochemical basis of enhanced drug bioavailability by
    piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp
    Ther 1985; 232: 258-62.

    13. Sreelal A M, Basavaraj G and Reshma S M: Critical analysis on pharmaceutics of alcoholic
    preparations (asava-arishta) in Ayurveda. JAHM 2013; 1:15.


    14. Krishnamachary B, Purushothaman A K, Pemiah B, Krishnaswamy S, Krishnan UM,
    Sethuraman S and Sekar RK: Bhanupaka: A Green Process in the Preparation of an Indian
    Ayurvedic Medicine, Lauha Bhasma. Journal of Chemistry 2013, Article ID 951951.

    15. Prakash B: Use of Metal in Ayurvedic Medicine. Indian J of History of science 1997; 32: 1-
    28.

    16. Shirwaikar A, Shirwaikar A, Prabhu SL and Kumar GA: Herbal Excipients in Novel Drug Delivery
    System.Indian J Pharm Sci 2008; 70: 415-22.

    17. Satturwar PM, Fulzele SV and Dorle AK: Biodegradation and in vivo biocompatibility of rosin: A
    natural film- forming polymer. AAPS Pharm Sci Tech 2003; 4: 1-6.

    18. Sharangdhar: Sharangdhar Samhita, Brahmanand Tripathi, Choukhambha Surbharati Prakasan,
    ed.2010, Madhyamkhand 1/6.

    19. Singh N and Chaudhary A: A comparative review study of Sneha Kalpana (Paka) vis-a-vis
    liposome. AYU 2011; 32: 103 - 08.

    20. Chaudhary A, Singh N, Dalvi M and Wele A: Progressive review of Sandhana kalpana (biomedical
    fermentation): an advanced innovative dosage form of Ayurveda. AYU 2011; 32: 408–17.

    21. Venkatarajua M P, Gowdaa D V, Rajeshb K S and Shivakumara H G:Xanthan and locust bean gum
    (from Ceratoniasiliqua) matrix tablets for oral controlled delivery of propranolol hydrochloride.
    Asian Journal of Pharmaceutical Sciences 2007; 2: 239-48.

    22. Drabu S, Khatri S, Babu S and Lohani P: Use of Herbal Bioenhancers to Increase the Bioavailability
    of Drugs. RJPBCS 2011; 2: 111.

    23. Principle of Drug Action: [Access on 15/09/2015]. Available from:
    http://www.ccras.nic.in/ayurveda/ Chapter-4%20 Drugs. pdf.

    24. Moribe K, Limwikrant W, Higashi K and Yamamoto K: Drug Nanoparticle Formulation Using
    Ascorbic Acid Derivatives. Journal of Drug Delivery Volume 2011; Article ID 138929: 1-9.

    25. Baldrick P: Pharmaceutical excipient development: the need for clinical guidance. Regul Toxicol
    Pharmacol 2000; 32: 210.

    26. Singh A, Tandon S, Sand NK. (2014) Active Ingredient Estimation of Clopyralid Formulation by
    Reversed Phase HPLC. J Chromatogr Sep Tech 6:257.

    27. Trivedi MK, Nayak G, Patil S, Tallapragada RM, Mishra R (2015) Influence of Biofield Treatment
    on Physicochemical Properties of Hydroxyethyl Cellulose and Hydroxypropyl Cellulose. J Mol
    Pharm Org Process Res 3: 126.

    28. Jain R, Sukla SK, Nema N, Panday A (2015) Drug Nano-particle: A Release Kinetics. J Nanomed
    Nanotechnol 6:317. doi:10.4172/2157-7439.

    29. Chauhan MK, Bhatt N (2015) A Simple and Modified Method Development of Vancomycin Using
    High Performance Liquid Chromatography. J Chromatogr Sep Tech 6:296.

    30. Mohd AB, Vemula SK (2016) Formulation and Pharmacokinetics of Vitamin E TPGS Melt
    Dispersion Granules: An Approach to Improve Oral Delivery of Flurbiprofen. J Bioequiv Availab
    8:089-94.

    31. Mukthinuthalapati MA, Bukkapatnam V (2015) A Novel Validated Stability- Indicating RP-HPLC
    Method for the Determination of Exemestane (Steroidal Aromatase Inhibitor). J Bioequiv Availab 7:288-292. doi:10.4172/jbb.1000256

    32. Jana S, Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, et al. (2015)
    Characterization of Physicochemical and Thermal Properties of Chitosan and Sodium Alginate
    after Biofield Treatment. Pharm Anal Acta 6:430.

    33. Patel P, Patel P, Giram P (2015) Bioanalytical Method Development and Validation for
    Latanoprost Quantification in Pharmaceutical Opthalmic Microemulsion Formulation by RP-
    HPLC. J Anal Bioanal Tech 6:284.

    34. Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, et al. (2015) Characterization of
    Physical, Thermal and Spectral Properties of Biofield Treated 2, 6-Diaminopyridine. J Develop
    Drugs

    35. Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, et al. (2015) Physical, Thermal
    and Spectral Properties of Biofield Energy Treated 2,4-Dihydroxybenzophenone. Clin Pharmacol
    Biopharm 4:145.

    37. Enose AA, Dasan P, Sivaramakrishanan H, Kakkar V (2016) Formulation, Characterization and
    Pharmacokinetic Evaluation of Telmisartan Solid Dispersions. J Mol Pharm Org Process Res
    4:131.

    39. Maroof K, Zafar F, Ali H, Naveed S, Tanwir S (2016) Scope of Nanotechnology in Drug Delivery.
    J Bioequiv Availab 8:001-005.

    40. Mohd AB, Vemula SK (2016) Formulation and Pharmacokinetics of Vitamin E TPGS Melt
    Dispersion Granules: An Approach to Improve Oral Delivery of Flurbiprofen. J Bioequiv Availab
    8:089-94.

    41. Krishnaiah YSR (2010) Pharmaceutical Technologies for Enhancing Oral Bioavailability of Poorly
    Soluble Drugs. J Bioequiv Availab 2: 028-036.

    42. Abdul Althaf S, Sailaja PB, Ashwin Kumar M (2012) Formulation, Evaluation and Mathematical
    Modelling of Clopidogrel Bisulphate & Aspirin Immediate Release Bilayer Tablets. Pharmaceut
    Anal Acta 3:194.

    43. Hart ML, Do DP, Ansari RA, Rizvi SAA (2013) Brief Overview of Various Approaches to Enhance
    Drug Solubility. J Develop Drugs 2: 115.

    44. Jethara SI, Patel MR (2015) Enhanced Solubility and Dissolution Rate of Aceclofenac by Using
    Spray Drying Techniques. Intel Prop Rights 3:140.

    45. Cavallari C, Fini A, Pérez-Artacho Santos B (2013) Thermal Study of Anhydrous and Hydrated
    Forms of Olanzapine. Pharm Anal Acta 4:237.

    46. Ertekin B, Çimen Z, Yilmaz H, Yilmaz UT (2016) Synthesis and Characterization of
    Polyaniline/Ignimbrite Nano-Composite Material. J Material Sci Eng 5: 237.

    47. Samanta A, Bandyopadhyay B, Das N (2016) Formulation of Catechin Hydrate Nanocapsule and
    Study of its Bioavailability. Med chem (Los Angeles) 6:399-404.

    49. Herman Ermens, A report of IPEC,Pharmaceutical Excipients – The Past and Future, Business
    Briefing. Pharmagenerics,2004.

    50. Baldrick P. Pharmaceutical excipient development: the need for clinical guidance, Regul Toxicol
    Pharmacol, 2000; 32: 210